(Press-News.org) New Rochelle, NY, May 9, 2013—Insomnia and other sleep disturbances are common among perimenopausal and postmenopausal women and may increase their risk of coronary heart disease (CHD) and cardiovascular disease (CVD). Evidence that a combination of altered sleep duration and insomnia among women ages 50-79 doubled their risk of both CHD and CVD over a period of more than 10 years is presented in an article in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website at http://www.liebertpub.com/jwh.
In "Sleep Duration, Insomnia, and Coronary Heart Disease among Postmenopausal Women in the Women's Health Initiative," Megan Sands-Lincoln, PhD, MPH and a team of researchers from leading medical institutions across the U.S. gathered self-reported data on sleep duration and insomnia in 86,329 women 50-79 years of age. Shorter (10 hours) sleep duration and insomnia were associated with higher incidence of CHD and CVD over 10.3 years, and when considered together, the interaction risk of insomnia and sleep duration was significant.
"This is the first study to investigate interactions of sleep duration with insomnia in relation to increased risk of CHD and CVD in postmenopausal women," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.
INFORMATION:
About the Journal
Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website at http://www.liebertpub.com/jwh. Journal of Women's Health is the Official Journal of the Academy of Women's Health and the Society for Women's Health Research.
About the Academy
Academy of Women's Health is an interdisciplinary, international association of physicians, nurses, and other health professionals who work across the broad field of women's health, providing its members with up-to-date advances and options in clinical care that will enable the best outcomes for their women patients. The Academy's focus includes the dissemination of translational research and evidence-based practices for disease prevention, diagnosis, and treatment of women across the lifespan.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Population Health Management, Thyroid, Metabolic Syndrome and Related Disorders, and Breastfeeding Medicine. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website at http://www.liebertpub.com.
Mary Ann Liebert, Inc. 140 Huguenot Street, New Rochelle, NY 10801 http://www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax (914) 740-2101
Do insomnia and disrupted sleep during menopause increase a woman's risk of heart disease?
2013-05-09
ELSE PRESS RELEASES FROM THIS DATE:
Mapping the embryonic epigenome
2013-05-09
May 9, 2013, New York, NY and San Diego, CA – A large, multi-institutional research team involved in the NIH Epigenome Roadmap Project has published a sweeping analysis in the current issue of the journal Cell of how genes are turned on and off to direct early human development. Led by Bing Ren of the Ludwig Institute for Cancer Research, Joseph Ecker of The Salk Institute for Biological Studies and James Thomson of the Morgridge Institute for Research, the scientists also describe novel genetic phenomena likely to play a pivotal role not only in the genesis of the embryo, ...
Research finds identifies social needs of young people with cancer
2013-05-09
New Orleans, LA – Research conducted by Xiao-Cheng Wu, MD, PhD, Associate Professor and Director of the Louisiana Tumor Registry at the LSU Health Sciences Center New Orleans School of Public Health, and colleagues, reports adolescents and young adults with cancer may be at higher risk for social isolation and that a substantial proportion of them have unmet social needs that could adversely affect their health. The research is published online in the Journal of Adolescent and Young Adult Oncology.
More than 500 participants in the Adolescent and Young Adult Health Outcomes ...
Methylphenidate 'normalizes' activation in key brain areas in kids with ADHD
2013-05-09
Philadelphia, Pa. (May 9, 2013) – The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Studies using functional magnetic resonance imaging (fMRI) show increased activation of key brain areas after a dose of methylphenidate in young patients with ADHD, according to the systematic review by Constance A. Moore, ...
Popular diabetes drug does not improve survival rates after cancer: Study
2013-05-09
TORONTO, ON, May 9, 2013 — Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.
The study, published in the journal Diabetes Care, failed to show an improved survival rate in older breast cancer patients with diabetes taking the drug metformin, a first-line treatment for diabetes. However, the authors caution further research is necessary to validate the study's ...
Loss of eastern hemlock will affect forest water use
2013-05-09
The loss of eastern hemlock from forests in the Southern Appalachian region of the United States could permanently change the area's hydrologic cycle, reports a new study by U.S. Forest Service scientists at the Coweeta Hydrologic Laboratory (Coweeta) located in Otto, North Carolina, published online in the journal Ecological Applications and available now in preprint format.
"The hemlock woolly adelgid, an exotic invasive insect, has caused widespread hemlock mortality," says Steven Brantley, a post-doctoral researcher at Coweeta and lead author of the paper. "Hemlock ...
Elevated cadmium levels linked to disease
2013-05-09
People with higher levels of cadmium in their urine — evidence of chronic exposure to the heavy metal found in industrial emissions and tobacco smoke — appear to be nearly 3.5 times more likely to die of liver disease than those with lower levels, according to a study by Johns Hopkins scientists.
The research findings do not show that cadmium directly causes liver disease, the scientists caution, but do suggest an association that needs more investigation.
Reviewing information from a large population-based survey, the Johns Hopkins investigators say the cadmium-liver ...
New advance in biofuel production
2013-05-09
Advanced biofuels – liquid fuels synthesized from the sugars in cellulosic biomass – offer a clean, green and renewable alternative to gasoline, diesel and jet fuels. Bringing the costs of producing these advanced biofuels down to competitive levels with petrofuels, however, is a major challenge. Researchers at the U.S. Department of Energy (DOE)'s Joint BioEnergy Institute (JBEI), a bioenergy research center led by Berkeley Lab, have taken another step towards meeting this challenge with the development of a new technique for pre-treating cellulosic biomass with ionic ...
Salk researchers chart epigenomics of stem cells that mimic early human development
2013-05-09
LA JOLLA, CA – Scientists have long known that control mechanisms known collectively as "epigenetics" play a critical role in human development, but they did not know precisely how alterations in this extra layer of biochemical instructions in DNA contribute to development.
Now, in the first comprehensive analysis of epigenetic changes that occur during development, a multi-institutional group of scientists, including several from the Salk Institute for Biological Studies, has discovered how modifications in key epigenetic markers influence human embryonic stem cells ...
Study finds that bacteria organize according to 'rich-get-richer' principle
2013-05-09
Bacteria on a surface wander around and often organize into highly resilient communities known as biofilms. It turns out that they organize in a rich-get-richer pattern similar to many economies, according to a new study by researchers at UCLA, Northwestern University and the University of Washington.
The study, published online May 8 in the journal Nature, is the first to identify the strategy by which bacteria form the micro-colonies that become biofilms, which can cause lethal infections. The research may have significant implications for battling stubborn bacterial ...
Doctor's choice of words may influence family's decision to permit CPR in critically ill
2013-05-09
PITTSBURGH, May 9, 2013 – A physician's choice of words when talking with family members about whether or not to try cardiopulmonary resuscitation (CPR) if a critically ill patient's heart stops may influence the decision, according to a study by University of Pittsburgh researchers in the June edition of Critical Care Medicine and now available online.
"It's long been known that the way a choice is framed can influence people's decisions," noted Amber E. Barnato, M.D., M.P.H., M.S., lead author of the study and associate professor of clinical and translational science ...